| 6849- | FBZ, | Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients |
| - | Case Report, | BC, | NA | - | Case Report, | Pca, | NA | - | Case Report, | Melanoma, | NA |
| 6850- | FBZ, | Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information |
| - | Case Report, | Lung, | NA |
| 6851- | FBZ, | Severe Drug-Induced Liver Injury Due to Self-administration of the Veterinary Anthelmintic Medication, Fenbendazole |
| - | Case Report, | Var, | NA |
| 6852- | FBZ, | Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report |
| - | Case Report, | Colon, | NA |
| 6853- | FBZ, | Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 6854- | FBZ, | Fenbendazole and its synthetic analog interfere with HeLa cells' proliferation and energy metabolism via inducing oxidative stress and modulating MEK3/6-p38-MAPK pathway |
| - | in-vitro, | Cerv, | HeLa |
| 6855- | FBZ, | Transcriptome analysis reveals the anticancer effects of fenbendazole on ovarian cancer: an in vitro and in vivo study |
| - | vitro+vivo, | Ovarian, | A2780S | - | vitro+vivo, | Ovarian, | SKOV3 |
| 6858- | FBZ, | Fenbendazole and Diisopropylamine Dichloroacetate Exert Synergistic Anti-cancer Effects by Inducing Apoptosis and Arresting the Cell Cycle in A549 Lung Cancer Cells |
| - | in-vitro, | Lung, | A549 |
| 6861- | FBZ, | Fenbendazole pharmacokinetics, metabolism, and potentiation in horses |
| - | in-vivo, | Nor, | NA |
| 6860- | FBZ, | IVM, | Drug-Induced Liver Injury Following Co-ingestion of Veterinary Fenbendazole and Ivermectin for Prostate Cancer: A Case Report |
| - | Case Report, | Pca, | NA |
| 6859- | FBZ, | DCA, | Synergistic anti-tumor effect of fenbendazole and diisopropylamine dichloroacetate in immunodeficient BALB/c nude mice transplanted with A549 lung cancer cells |
| - | in-vivo, | Lung, | A549 |
| 6857- | FBZ, | Fenbendazole induces pyroptosis in breast cancer cells through HK2/caspase-3/GSDME signaling pathway |
| - | vitro+vivo, | BC, | NA |
| 2499- | FBZ, | VitE, | Effects of fenbendazole and vitamin E succinate on the growth and survival of prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
| 2498- | FBZ, | Unexpected Antitumorigenic Effect of Fenbendazole when Combined with Supplementary Vitamins |
| - | in-vivo, | lymphoma, | NA |
| 2494- | FBZ, | Oral Fenbendazole for Cancer Therapy in Humans and Animals |
| - | Review, | Var, | NA |
| 2495- | FBZ, | Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells |
| - | in-vitro, | Melanoma, | A375 |
| 2496- | FBZ, | Impairment of the Ubiquitin-Proteasome Pathway by Methyl N-(6-Phenylsulfanyl-1H-benzimidazol-2-yl)carbamate Leads to a Potent Cytotoxic Effect in Tumor Cells |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | NSCLC, | H460 |
| 2497- | FBZ, | In vitro anti-tubulin effects of mebendazole and fenbendazole on canine glioma cells |
| - | in-vitro, | GBM, | NA |
| 6430- | FEO, | Foeniculum vulgare: A comprehensive review of its traditional use, phytochemistry, pharmacology, and safety |
| - | Review, | Nor, | NA |
| 6426- | FEO, | Foeniculum Vulgare and Pelargonium Graveolens Essential Oil Mixture Triggers the Cell Cycle Arrest and Apoptosis in MCF-7 Cells |
| - | in-vitro, | BC, | MCF7 |
| 6427- | FEO, | Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma |
| - | vitro+vivo, | HCC, | NA |
| 6428- | FEO, | Eug, | Triggering of apoptosis and cell cycle arrest by fennel and clove oils in Caco-2 cells: the role of combination |
| - | in-vitro, | Colon, | Caco-2 |
| 6893- | Fer, | VitC, | MRI Detection and Therapeutic Enhancement of Ferumoxytol Internalization in Glioblastoma Cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U118MG |
| 6892- | Fer, | MR Imaging of Tumor Associated Macrophages with Clinically-Applicable Iron Oxide Nanoparticles |
| - | in-vivo, | Var, | NA |
| 6891- | Fer, | Iron oxide nanoparticles inhibit tumor growth by ferroptosis in diffuse large B-cell lymphoma |
| - | vitro+vivo, | lymphoma, | NA |
| 6890- | Fer, | Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues |
| - | vitro+vivo, | Var, | NA |
| 1914- | Fer, | VitC, | TMZ, | Rad, | Pharmacologic Ascorbate and Ferumoxytol Combined with Temozolomide and Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma |
| - | Trial, | GBM, | NA |
| 1915- | Fer, | Vascular Imaging With Ferumoxytol as a Contrast Agent |
| - | Analysis, | Var, | NA |
| - | in-vitro, | CRC, | NA |
| 6897- | FIS, | Fisetin: A Dietary Antioxidant for Health Promotion |
| - | Review, | Nor, | NA |
| - | in-vitro, | Cerv, | NA |
| 6906- | FIS, | Rad, | Combining fisetin and ionizing radiation suppresses the growth of mammalian colorectal cancers in xenograft tumor models |
| - | in-vivo, | CRC, | CT26 | - | in-vivo, | CRC, | HCT116 |
| 6907- | FIS, | Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors |
| - | in-vitro, | AD, | NA |
| 6903- | FIS, | Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549 |
| - | in-vitro, | Lung, | A549 |
| 6908- | FIS, | Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice |
| - | in-vivo, | AD, | NA |
| 6909- | FIS, | Modulation of PI3K/ AKT/ mTOR and apoptosis pathway in colon cancer cells by the plant flavonoid fisetin |
| - | in-vitro, | Colon, | Caco-2 |
| 6910- | FIS, | Exploring the therapeutic promise of fisetin: molecular mechanisms and clinical aspects in lung cancer |
| - | in-vitro, | Lung, | NA |
| 6911- | FIS, | New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells |
| - | vitro+vivo, | BC, | NA |
| 6912- | FIS, | Cancer chemopreventive role of fisetin: Regulation of cell signaling pathways in different cancers |
| - | Review, | Var, | NA |
| 6913- | FIS, | Fisetin inhibits tau aggregation by interacting with the protein and preventing the formation of β-strands |
| - | in-vitro, | AD, | NA |
| 6914- | FIS, | Fisetin inhibits inflammation and induces autophagy by mediating PI3K/AKT/mTOR signaling in LPS-induced RAW264.7 cells |
| - | in-vitro, | Nor, | RAW264.7 |
| 6915- | FIS, | SRF, | Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma |
| - | in-vitro, | Melanoma, | NA |
| 6916- | FIS, | Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways |
| - | in-vitro, | BC, | MCF7 |
| 6917- | FIS, | Dietary flavonoid fisetin regulates aluminium chloride-induced neuronal apoptosis in cortex and hippocampus of mice brain |
| - | in-vivo, | AD, | NA | - | in-vivo, | Park, | NA |
| 6918- | FIS, | Geld, | Radic, | HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells |
| - | in-vitro, | CRC, | COLO205 |
| 6919- | FIS, | Inhibition of c-Jun N-terminal kinase and nuclear factor κ B pathways mediates fisetin-exerted anti-inflammatory activity in lipopolysccharide-treated RAW264.7 cells |
| - | in-vitro, | Var, | NA |
| 6920- | FIS, | A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design |
| - | Trial, | BC, | NA |
| 6921- | FIS, | The Effects of Fisetin on Reducing Biological Aging: A Pilot Study |
| - | Human, | Nor, | NA |
| 6922- | FIS, | Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin |
| - | Review, | Var, | NA |
| 6901- | FIS, | Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21Cip1 and p27Kip1 leading to apoptosis and tumor growth inhibition in HNSCC |
| - | in-vivo, | HNSCC, | CAL33 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid